The store will not work correctly when cookies are disabled.
sodium (E)-((5-hydroxy-4-methylpent-3-enyl)oxidophosphoryl)methylphosphonate
ID: ALA4089656
PubChem CID: 137641445
Max Phase: Preclinical
Molecular Formula: C7H13Na3O6P2
Molecular Weight: 258.15
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=C\CCP(=O)([O-])CP(=O)([O-])[O-])CO.[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C7H16O6P2.3Na/c1-7(5-8)3-2-4-14(9,10)6-15(11,12)13;;;/h3,8H,2,4-6H2,1H3,(H,9,10)(H2,11,12,13);;;/q;3*+1/p-3/b7-3+;;;
Standard InChI Key: KXFOALMBZYBRLI-XAEFZVGHSA-K
Molfile:
RDKit 2D
18 14 0 0 0 0 0 0 0 0999 V2000
17.1899 -25.5517 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
16.6369 -23.6903 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
15.9270 -24.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2212 -23.6903 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
16.6369 -22.8731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2171 -24.5034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2212 -22.8731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3899 -23.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0957 -24.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3426 -24.0989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6327 -24.5034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5113 -24.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8056 -23.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9743 -23.6903 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6842 -24.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3899 -22.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9612 -25.4567 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
18.0236 -23.8182 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
3 2 1 0
4 3 1 0
5 2 2 0
6 4 1 0
7 4 2 0
8 9 2 0
9 13 1 0
10 2 1 0
11 2 1 0
12 4 1 0
13 12 1 0
14 15 1 0
15 8 1 0
16 8 1 0
M CHG 6 1 1 6 -1 10 -1 11 -1 17 1 18 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 258.15 | Molecular Weight (Monoisotopic): 258.0422 | AlogP: 0.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 115.06 | Molecular Species: ACID | HBA: 3 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.32 | CX Basic pKa: ┄ | CX LogP: -1.48 | CX LogD: -6.15 |
Aromatic Rings: ┄ | Heavy Atoms: 15 | QED Weighted: 0.41 | Np Likeness Score: 1.44 |
References
1. Shippy RR, Lin X, Agabiti SS, Li J, Zangari BM, Foust BJ, Poe MM, Hsiao CC, Vinogradova O, Wiemer DF, Wiemer AJ.. (2017) Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism., 60 (6): [PMID:28218845] [10.1021/acs.jmedchem.6b00965] |